98%
921
2 minutes
20
Introduction: This study longitudinally describes the relationship between frequency of e-cigarette use and past-month cigarette abstinence, dual use, and maintenance of cigarette smoking among adults in the US who ever used e-cigarettes for cigarette cessation.
Methods: Data were from the US Population Assessment of Tobacco and Health Study Waves 5 (2018/19; baseline) and 6 (2021; follow-up). The sample was restricted to adults who used cigarettes and e-cigarettes in the past-month and ever used e-cigarettes to quit smoking at baseline. The primary predictor was baseline daily e-cigarette-use, and outcomes at follow-up were past-month cigarette abstinence, and multiple past-month cessation outcomes: a. cigarette maintenance; b. dual use; c. dual abstinence; and, d. past-month cigarette abstinence. We used weighted multivariable logistic and multinomial regression models, adjusting for demographics and baseline daily cigarette smoking.
Results: Among adults who ever used e-cigarettes to quit cigarettes, more daily e-cigarette users than non-daily (36.7 % vs 8.4 %) were cigarette abstinent and had higher odds of cigarette abstinence at follow-up (AOR:1.9, 95 % CI:1.1, 3.2). Daily e-cigarette (vs. non-daily) users had a higher likelihood of cigarette abstinence than cigarette maintenance (RRR:7.1, 95 % CI:3.8, 13.0). Compared to dual use, there was a higher likelihood of cigarette abstinence among daily e-cigarette users (vs. non-daily) (RRR:2.7; 95 % CI:1.5,4.9).
Conclusions: Daily e-cigarette use among individuals who used e-cigarettes to quit cigarette smoking predicts past-month cigarette abstinence. Daily e-cigarette use is associated with a higher likelihood of cigarette abstinence than cigarette maintenance, and a higher likelihood of cigarette abstinence than dual use at follow-up.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.addbeh.2025.108458 | DOI Listing |
Tob Control
September 2025
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA
Background: As part of its COVID-19 response, South Africa banned tobacco sales between March and August 2020. We examined self-reported tobacco use before, during and after the ban among a rural South African population with high HIV prevalence.
Methods: Between May 2021 and November 2022, we conducted a telephonic survey on tobacco use among a purposively selected subset of a population-based cohort in rural KwaZulu-Natal.
J Affect Disord
September 2025
Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, 1845 N. Soto St., Los Angeles, CA, 90032, USA; Department of Psychology, University of Southern California, 3620 McClintock Ave., Los Angeles, CA, 90089, USA.
Introduction: Individuals with elevated depression symptoms experience low positive affect, high negative affect, and cognitive dysfunction. Affective and cognitive disruptions also occur during cigarette abstinence. This study examined whether depression symptom levels associate with affect and cognitive dysfunction during a cigarette quit attempt.
View Article and Find Full Text PDFCJC Open
August 2025
University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Background: Cytisine use has proven efficacy for smoking cessation. We plan to investigate whether cytisine use is effective for relapse recovery and conducted a pilot randomized trial to assess the feasibility of a definitive trial.
Methods: A 2-group, single-site pilot randomized controlled trial was conducted.
Addict Behav
August 2025
Department of Health Behavior, Policy, and Administration Sciences, University of Nevada, Reno, NV, USA.
Introduction: This study longitudinally describes the relationship between frequency of e-cigarette use and past-month cigarette abstinence, dual use, and maintenance of cigarette smoking among adults in the US who ever used e-cigarettes for cigarette cessation.
Methods: Data were from the US Population Assessment of Tobacco and Health Study Waves 5 (2018/19; baseline) and 6 (2021; follow-up). The sample was restricted to adults who used cigarettes and e-cigarettes in the past-month and ever used e-cigarettes to quit smoking at baseline.
Nicotine Tob Res
August 2025
NFL Biosciences, Castelnau-Le-Lez, France.
Introduction: Tobacco addiction remains a major public health challenge. Existing smoking cessation treatments require prolonged daily use with potentially poor adherence and reduced efficacy.
Methods: The phase II study was a multicenter, randomized, double-blind, placebo-controlled trial with a one-year follow-up to assess the efficacy, safety, and immunogenicity of NFL-101 as a potential aid for smoking cessation.